Skip to main content

Y Shu

First name:
Y
Last name:
Shu
Hu, X., Li, L., Yu, X., Zhang, R., Yan, S., Zeng, Z., et al. (2017). CRISPR/Cas9-mediated reversibly immortalized mouse bone marrow stromal stem cells (BMSCs) retain multipotent features of mesenchymal stem cells (MSCs). Oncotarget, 8(67), 111847-111865. https://doi.org/10.18632/oncotarget.22915 (Original work published 2017)
Zhou, Y., Liu, X., Jiang, W., & Shu, Y. (2018). Theoretical insight into reaction mechanisms of 2,4-dinitroanisole with hydroxyl radicals for advanced oxidation processes. Journal Of Molecular Modeling, 24(2), 44. https://doi.org/10.1007/s00894-018-3580-4 (Original work published 2018)
Purdum, G. E., Telesz, N. G., Jarolimek, K., Ryno, S. M., Gessner, T., Davy, N. C., et al. (2018). Presence of Short Intermolecular Contacts Screens for Kinetic Stability in Packing Polymorphs. Journal Of The American Chemical Society, 140(24), 7519-7525. https://doi.org/10.1021/jacs.8b01421 (Original work published 2018)
Huang, J., Xiao, J., Fang, W., Lu, P., Fan, Q., Shu, Y., et al. (2021). Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double-blind randomized phase 2 trial. Cancer Medicine, 10(5), 1681-1689. https://doi.org/10.1002/cam4.3771